DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Nystrom T, Bodegard J, Nathanson D. et al.
Novel oral glucose lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetes.
Diabetes Obes Metab 2017;
19: 831-841
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.